Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunal Desai

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Endocrinology|May 19, 2011
Effects of peripherally administered neuromedin U on energy and glucose homeostasisAndrea M Peier, Kunal Desai, James Hubert, et al.
Bioorganic & Medicinal Chemistry|July 10, 2012
PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetesPaolo Ingallinella, Andrea M Peier, Alessandro Pocai, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 14, 2013
Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptidePhilippe Neuner, Andrea M Peier, Fabio Talamo, et al.
Blood Advances|March 4, 2021
MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell diseaseMelanie Demers, Sarah Sturtevant, Kevin R Guertin, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Androgen blockade primes NLRP3 in macrophages to induce tumor phagocytosisKiranj Chaudagar, Srikrishnan Rameshbabu, Shenglin Mei, et al.
Thrombosis and Haemostasis|March 20, 2015
Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liabilityJoseph M Metzger, Marija Tadin-Strapps, Anil Thankappan, et al.
Journal for Immunotherapy of Cancer|October 17, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinomaLandon C Brown, Jason Zhu, Kunal Desai, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2015
Development of a novel class of potent and selective FIXa inhibitorsTing Zhang, Patrick Andre, Thomas J Bateman, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2015
Development of a novel tricyclic class of potent and selective FIXa inhibitorsDongfang Meng, Patrick Andre, Thomas J Bateman, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Endocrinology|May 19, 2011
Effects of peripherally administered neuromedin U on energy and glucose homeostasisAndrea M Peier, Kunal Desai, James Hubert, et al.
Bioorganic & Medicinal Chemistry|July 10, 2012
PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetesPaolo Ingallinella, Andrea M Peier, Alessandro Pocai, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 14, 2013
Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptidePhilippe Neuner, Andrea M Peier, Fabio Talamo, et al.
Blood Advances|March 4, 2021
MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell diseaseMelanie Demers, Sarah Sturtevant, Kevin R Guertin, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Androgen blockade primes NLRP3 in macrophages to induce tumor phagocytosisKiranj Chaudagar, Srikrishnan Rameshbabu, Shenglin Mei, et al.
Thrombosis and Haemostasis|March 20, 2015
Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liabilityJoseph M Metzger, Marija Tadin-Strapps, Anil Thankappan, et al.
Journal for Immunotherapy of Cancer|October 17, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinomaLandon C Brown, Jason Zhu, Kunal Desai, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2015
Development of a novel class of potent and selective FIXa inhibitorsTing Zhang, Patrick Andre, Thomas J Bateman, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2015
Development of a novel tricyclic class of potent and selective FIXa inhibitorsDongfang Meng, Patrick Andre, Thomas J Bateman, et al.
Pageof 3